EUVIMEDEUVIMED entdecken
Crossref

C5aR1 and C5aR2 deficiency confer different degrees of protection against imiquimod-induced psoriasiform dermatitis

Jeffrey Damman iD, Koen Dudink, Anne-Marie Mus, Priyanka S Bangoer, Thierry P P van den Bosch iD, Antien L Mooyaart, Felix Poppelaars, Errol P Prens, Marc A Seelen, Erik Lubberts

Clinical and Experimental Immunology · 30.10.2026

DOI: 10.1093/cei/uxag070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Immunology, online erschienen am 30.10.2026. Verfasst von Jeffrey Damman und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriasis pathogenesis comprises both auto-immune and auto-inflammatory aspects. We hypothesized that complement anaphylatoxin C5a plays an important role in the pathogenesis of psoriasis via C5a receptor (C5aR) 1 and C5aR2 activation on neutrophils and through regulation of C5aR dependent IL-17/IL-23-mediated adaptive immune activation. The imiquimod (IMQ)-induced psoriasiform dermatitis mouse model was used. Wildtype (WT), C5ar1-/- and C5ar2-/- mice received a daily topical dose of IMQ cream on the shaved back for three or up to five consecutive days. Skin inflammation was assessed visually (modified mouse Psoriasis Area and Severity Index (PASI)), by histology, immunohistochemistry and gene expression of cytokines in the skin were measured by qPCR. Serum IL-17A was analyzed by ELISA. Compared to WT, C5ar1-/- mice demonstrated lower gene expression of IL-1β in the skin after three days and decreased influx of neutrophils, monocytes/macrophages, C9 deposition and circulating IL-17A after five days of IMQ treatment. Epidermal thickness and PASI-scores were significantly decreased in C5ar1-/- mice compared to WT at day five. C5ar2-/- mice showed mild protection on epidermal thickening after five days and demonstrated higher local IL-17F and systemic IL-17A responses after three days. This study shows a detrimental role for C5aR1 in the pathogenesis of psoriasiform dermatitis in mice and confirms the link between C5a-C5aR1, IL-1β and IL-17A. C5ar2-/- mice showed only modest protection against IMQ-induced psoriasiform dermatitis. Therefore, inhibition of the C5a-C5aR1 axis might be a promising novel approach in the treatment of psoriasis.

Schlagwörter

Stichwörter der Autor:innen

C5aPsoriasiscomplementimiquimodreceptorskin

Autor:innen und Institutionen

  • Department of Pathology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Department of Dermatology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Department of Rheumatology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Department of Internal Medicine, Division of Nephrology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

ORCID-Profile: Jeffrey Damman, Thierry P P van den Bosch

Zitieren

APA

Damman, J., Dudink, K., Mus, A. M., Bangoer, P. S., van den Bosch, T. P. P., Mooyaart, A. L., Poppelaars, F., Prens, E. P., Seelen, M. A., & Lubberts, E. (2026). C5aR1 and C5aR2 deficiency confer different degrees of protection against imiquimod-induced psoriasiform dermatitis. Clinical and Experimental Immunology. https://doi.org/10.1093/cei/uxag070

Vancouver

Damman J, Dudink K, Mus AM, Bangoer PS, van den Bosch TPP, Mooyaart AL, et al. C5aR1 and C5aR2 deficiency confer different degrees of protection against imiquimod-induced psoriasiform dermatitis. Clinical and Experimental Immunology. 2026. doi:10.1093/cei/uxag070

BibTeX
@article{Damman2026,
  author = {Damman, Jeffrey and Dudink, Koen and Mus, Anne-Marie and Bangoer, Priyanka S and van den Bosch, Thierry P P and Mooyaart, Antien L and Poppelaars, Felix and Prens, Errol P and Seelen, Marc A and Lubberts, Erik},
  title = {C5aR1 and C5aR2 deficiency confer different degrees of protection against imiquimod-induced psoriasiform dermatitis},
  journal = {Clinical and Experimental Immunology},
  year = {2026},
  doi = {10.1093/cei/uxag070}
}
Kostenlos starten →